Items
Login
Register
Toggle Navigation
Compounding Still in the Mix On-Demand Webinar
Quantity
Add to Cart
Back to Results
Recorded May 18, 2017 | On-Demand Webinar
In the three years since the DQSA’s Compounding Quality Act (CQA) took effect there have been significant legal and regulatory developments in drug compounding. Learn where compounders, FDA, States, Congress, and pharmaceutical companies stand on the many issues affecting this important, yet challenging, practice. Speakers will cover pressing issues such as the still-unsettled office use compounding debate, FDA’s draft guidance on “essentially copies” of approved drugs, the status of FDA’s draft MOU addressing interstate shipments, and the status of FDA’s “Bulks Lists.” An analysis of what is on the horizon for compounders from a regulatory (FDA and state inspections) and legal (actions for non-compliance) perspective will be provided.
J. Andrew Harrison, Vice President, Legal & Compliance, PharMEDium Services, LLC, an AmerisourceBergen Corporation Company
Elizabeth Jungman, Director, Public Health Programs, The Pew Charitable Trusts
Moderated by Karla L. Palmer, Director, Hyman, Phelps & McNamara
IE and Edge users: Microsoft Internet Explorer (IE) and Edge are not supported by the checkout process.
Please use Chrome, Firefox, or Safari. If you are unable to use these browsers, please contact us at 202-371-1420 or
[email protected]
and we will assist you in your purchase.
Assign Members :
Members Assigned |
Assign all contacts
Unassign all contacts
View :
All
Assigned
Unassigned
Add New Contact
Add New Contact
Cancel
Save
Assign
Full Name
Account Name
Email
Role
Total Records
- Showing Page
Discounts and special pricing for additional items will be applied once you add the item to your cart.